Scientific Project 1: Malaria Immune Responses to Pre-erythrocytic Malaria Vaccination or Infection
Scientific Project 1: Malaria Immune Responses to Pre-erythrocytic Malaria Vaccination or Infection
批准号:
10419584
负责人:
KENNETH D STUART
金额:
$38.05万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-07-19 至 2027-04-30
关键词:
Adaptive Immune SystemAffectAntibodiesAntibody ResponseAntigen ReceptorsAntigensAttenuatedB-LymphocytesBenchmarkingBiological AssayCell LineageCell physiologyCellsCharacteristicsDevelopmentErythrocytesEvaluationEventFalciparum MalariaFingerprintFutureGenerationsGeneticGenetic ProgrammingGenetic TranscriptionGoalsHIVHumanHuman CharacteristicsImmuneImmune responseImmune systemImmunityImmunizationImmunologicsImmunologyInfectionLeadMalariaMalaria VaccinesMediatingMediator of activation proteinMethodsMolecularMonoclonal AntibodiesMultiparametric AnalysisOutcomePathway interactionsPeptidesPeripheral Blood Mononuclear CellPhenotypePlasmodium falciparumPopulationProcessSARS-CoV-2 infectionSamplingSerumSignal TransductionSporozoitesStainsSystemSystems BiologyT cell responseT-LymphocyteTestingVaccinationVaccinesVariantadaptive immunitybasecytokinehigh dimensionalityimprovedinsightmalaria infectionmonocytemultiple omicsresponsesingle cell sequencingtherapy developmentvaccine developmentvaccine efficacyvaccine responsevaccine trial
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Scientific Project 1: Immune Responses to Pre-erythrocytic Malaria Vaccination or Infection
Abstract
This project will identify and characterize key characteristics of human immune responses to the pre-erythrocytic
(PE) falciparum malaria infection and vaccination that targets this stage with a focus on responses that correlate
with protection or infection. We hypothesize that responses by protected vs. not protected, and infected subjects
will identify the relevant immune constituents and processes. We will use complementary immunological
analyses and systems immunology approaches and characterize responses in the innate and adaptive immune
compartments to identify cellular and humoral responses that correlate with protection or infection. We will: 1.
Define cellular and soluble mediators of early innate responses and test the hypothesis that innate response
variations affect adaptive responses and are predictive of protective immunity development. We will also analyze
the influence of prior malaria exposure on vaccine efficacy. 2. Define the stimulation and temporal programming
of vaccine-elicited protective adaptive immune cells with a focus on the stimulation, signaling, and programming
of T and B cells and which pathways lead to protective phenotypes. We hypothesize that key signaling and
maturation pathways lead to protective adaptive immunity. Details of antigen receptor usage, cell lineages,
transcriptional programming, and phenotypic changes will be integrated with innate signaling events to define
events that shepherd cells through recall and maturation during immunization. 3. Connect protective phenotypes
with adaptive immune functional activity to identify functional characteristics of cellular and humoral
responses that correlate with protection. Antigen specific reactive T cell responses will be analyzed by
cytometric, functional, single-cell sequencing, and multi-omics methods. B functions will be analyzed by
deep multi-parametric analysis of sera and monoclonal antibodies. This will identify key functional characteristics
of cell populations and antibodies that are associated with immune protection. Integration of cell phenotypes and
functional activities of multiple immune compartments will give insights into immune signatures and processes
that define protective responses to malaria vaccines and provide benchmarks to guide vaccine development.
Overall, our integrated immunological and systems biology analyses of samples from malaria vaccine trials will
identify immune signatures during critical stages following vaccination which correlate with protection against
malaria or result from its infection and advance understanding of factors that impact development of elicited
protective immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collective Responses to Malaria Vaccination
-
批准号:10569619
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2022
-
负责人:KENNETH D STUART
-
依托单位:
Collective Responses to Malaria Vaccination
-
批准号:10343347
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2022
-
负责人:KENNETH D STUART
-
依托单位:
Administrative Core
-
批准号:10631087
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Administrative Core
-
批准号:10419581
-
项目类别:
-
资助金额:$15.22万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Scientific Project 1: Malaria Immune Responses to Pre-erythrocytic Malaria Vaccination or Infection
-
批准号:10631098
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Immune Responses Associated with Malaria Infection and Immune Protection - Project 1
-
批准号:10198681
-
项目类别:
-
资助金额:$76.46万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Immune Responses to Malaria and HIV Infection and Immunization
-
批准号:10198675
-
项目类别:
-
资助金额:$356.11万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Immune Responses to Malaria and HIV Infection and Immunization - Administrative Core
-
批准号:10198676
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Immune Responses to Malaria and HIV Infection and Immunization
-
批准号:9816741
-
项目类别:
-
资助金额:$267.54万
-
财政年份:2017
-
负责人:KENNETH D STUART
-
依托单位:
Genome wide assessment of essential genes in Trypanosoma brucei
-
批准号:8204844
-
项目类别:
-
资助金额:$83.29万
-
财政年份:2010
-
负责人:KENNETH D STUART
-
依托单位:
Genome wide assessment of essential genes in Trypanosoma brucei
-
批准号:8009412
-
项目类别:
-
资助金额:$82.72万
-
财政年份:2010
-
负责人:KENNETH D STUART
-
依托单位:
Administrative Core
-
批准号:7994287
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2010
-
负责人:KENNETH D STUART
-
依托单位:
Genome wide assessment of essential genes in Trypanosoma brucei
-
批准号:7782180
-
项目类别:
-
资助金额:$87.38万
-
财政年份:2010
-
负责人:KENNETH D STUART
-
依托单位:
Research Training on Intracellular Pathogens
-
批准号:7911351
-
项目类别:
-
资助金额:$1.19万
-
财政年份:2009
-
负责人:KENNETH D STUART
-
依托单位:
Trypanosome Drug Development Consortium
-
批准号:7492286
-
项目类别:
-
资助金额:$41.21万
-
财政年份:2007
-
负责人:KENNETH D STUART
-
依托单位:
Trypanosome Drug Development Consortium
-
批准号:7684270
-
项目类别:
-
资助金额:$42.55万
-
财政年份:2007
-
负责人:KENNETH D STUART
-
依托单位:
Trypanosome Drug Development Consortium
-
批准号:7932292
-
项目类别:
-
资助金额:$43.22万
-
财政年份:2007
-
负责人:KENNETH D STUART
-
依托单位:
Trypanosome Drug Development Consortium
-
批准号:7326373
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2007
-
负责人:KENNETH D STUART
-
依托单位:
Trypanosome Drug Development Consortium
-
批准号:8131789
-
项目类别:
-
资助金额:$42.87万
-
财政年份:2007
-
负责人:KENNETH D STUART
-
依托单位:
T. brucei Mitochondrial Proteome
-
批准号:6959211
-
项目类别:
-
资助金额:$63.87万
-
财政年份:2005
-
负责人:KENNETH D STUART
-
依托单位:
海外基金